Literature DB >> 26058279

The results of pterygium excision at Thammasat Hospital.

Kosol Kampitak, Anant Bhornmata.   

Abstract

BACKGROUND: Pterygium is a common ocular disease. Outcomes ofpterygium surgery are variable.
OBJECTIVE: To evaluate the results ofpterygium excision, particularly the recurrence rate and complications of surgery. MATERIAL AND
METHOD: Patient data who had pterygium excision at Thammasat Hospital from October 2010 to September 2013 were reviewed. Age, sex, primary or secondary pterygium, methods of surgery and complications were analyzed.
RESULTS: Three hundred and thirty-four eyes (307 patients) were studied. One hundred and ninety-two (62.5%) were in women. The mean age ± SD was 57.1 ± 12.2 years. Three hundred and twenty-two eyes (96.4%) were primary pterygium. Amniotic membrane graft technique was performed in 323 eyes (96.7%). Pterygium recurred after surgery in 80 eyes (24.0%). Intra-ocular pressure increased more than five mmHg in 34 eyes (10.2%) after steroids use. Scleral thinning was found infive eyes (1.5%) and four in this group were treated with Mitomycin C. There was granulation tissue formation in one eye (0.3%).
CONCLUSION: Pterygium excision with amniotic membrane graft technique was widely operated at Thammasat Hospital and recurrence after surgery was rather high. Increased intra-ocular pressure after steroids use was common complication. Scleral thinning was a critical problem with the application of Mitomycin C.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26058279

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

1.  Efficacy and Safety of Amniotic Membrane Transplantation Combined with Closure of Tenon Capsule and Bulbar Conjunctival Space in the Treatment of Primary Pterygium.

Authors:  Jingyao Chen; Yixin Zheng; Weijia Zhang; Zijun Zhao; Yanze Xu
Journal:  Contrast Media Mol Imaging       Date:  2022-09-02       Impact factor: 3.009

2.  A Survey of Surgical Techniques in Pterygium, Thailand 2016.

Authors:  Saovapak Phathanthurarux; Patchima Chantaren
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019 Nov-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.